» Authors » Satoshi Fuke

Satoshi Fuke

Explore the profile of Satoshi Fuke including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 704
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugawara H, Date A, Fuke S, Nakachi Y, Kato T, Narita M, et al.
Neuropsychopharmacol Rep . 2023 Dec; 44(1):250-255. PMID: 38058257
Quantifying cytosine modifications in various brain regions provides important insights into the gene expression regulation and pathophysiology of neuropsychiatric disorders. In this study, we quantified 5-methylcytosine (5-mC), 5-hydroxymethylation (5-hmC), and...
2.
Murakami K, Kubota S, Tanaka K, Tanaka H, Akabane K, Suzuki R, et al.
Lab Chip . 2023 Oct; 23(22):4909-4918. PMID: 37877206
A digital platform that can rapidly and accurately diagnose pathogenic viral variants, including SARS-CoV-2, will minimize pandemics, public anxiety, and economic losses. We recently reported an artificial intelligence (AI)-nanopore platform...
3.
Tanaka A, Fujimura Y, Fuke S, Izumi K, Ujiie H
J Dermatol . 2023 May; 50(9):1199-1202. PMID: 37122191
Bullous pemphigoid (BP) is an autoimmune disease characterized by itchy erythema and tense blisters on the whole body. Recent reports have unveiled the pathogenic roles of eosinophils in BP (e.g.,...
4.
Kataoka K, Nishiyama O, Ogura T, Mori Y, Kozu R, Arizono S, et al.
Thorax . 2023 Apr; 78(8):784-791. PMID: 37012071
Background: Idiopathic pulmonary fibrosis (IPF) is characterised by worsening dyspnoea and exercise intolerance. Research Question: Does a long-term pulmonary rehabilitation improve exercise tolerance in patients with IPF treated with standard...
5.
Wang Q, Edahiro R, Namkoong H, Hasegawa T, Shirai Y, Sonehara K, et al.
Nat Commun . 2022 Aug; 13(1):4830. PMID: 35995775
Coronavirus disease 2019 (COVID-19) is a recently-emerged infectious disease that has caused millions of deaths, where comprehensive understanding of disease mechanisms is still unestablished. In particular, studies of gene expression...
6.
Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, et al.
Nature . 2022 Aug; 609(7928):754-760. PMID: 35940203
Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge. Here we conducted a genome-wide association study (GWAS) involving 2,393 cases of COVID-19 in a cohort of Japanese...
7.
Nagata K, Horie T, Chohnabayashi N, Jinta T, Tsugitomi R, Shiraki A, et al.
Am J Respir Crit Care Med . 2022 Jun; 206(11):1326-1335. PMID: 35771533
The long-term effects of using a high-flow nasal cannula for chronic hypercapnic respiratory failure caused by chronic obstructive pulmonary disease remain unclear. To assess whether long-term high-flow nasal cannula use...
8.
Kagami K, Ishiguro N, Iwasaki S, Usami T, Fukumoto T, Hayasaka K, et al.
Am J Infect Control . 2022 Jun; 51(2):163-171. PMID: 35671846
Background: The Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system aggregates information related to antimicrobial resistance (AMR) measures in participating medical institutions nationwide and is intended to be...
9.
Kuroki R, Murata Y, Fuke S, Nakachi Y, Nakashima J, Kujoth G, et al.
Front Genet . 2020 Nov; 11:519206. PMID: 33193604
The retrotransposon long interspersed nuclear element-1 (LINE-1) can autonomously increase its copy number within a host genome through the retrotransposition process. LINE-1 is active in the germline and in neural...
10.
Makita H, Suzuki M, Konno S, Shimizu K, Nasuhara Y, Nagai K, et al.
Int J Chron Obstruct Pulmon Dis . 2020 Sep; 15:2081-2090. PMID: 32943861
Purpose: Causes of death may be unique and different in Japanese patients with COPD because they are generally older, thinner, experience fewer exacerbations, and live longer than those in other...